Nam Son Nguyen, NP
Family · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nam Son Nguyen’s office at (408) 503-7600 to ask if they take your plan before you enroll.
Medicaid work
$3,772 in 2024
Medicaid paid $3,772 for 1,159 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 106 | $2,259 |
| Short return visit (20+ min) | 144 | $1,513 |
| Pain severity quantified; no pain present (COA) (ONC) | 19 | $0 |
| Medication list documented in medical record (COA) | 200 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 195 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 239 | $0 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 256 | $0 |
| 2024 | 1,159 | 7 | 30 | $3,772 |
| 2023 | 42 | 2 | 13 | $284 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 22 | $284 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 20 | $0 |
Drugs they prescribed that Part D paid
$797,481
Pharmacies billed $797,481 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,607 generic and 830 brand-name prescriptions · $797,481 in drug cost · 38 antibiotic prescriptions to 36 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 197 | $235,706 | $1,196 |
| Rybelsus | 134 | $186,434 | $1,391 |
| Ozempic | 108 | $121,341 | $1,124 |
| Mounjaro | 55 | $57,223 | $1,040 |
| Trulicity | 39 | $35,483 | $910 |
See all 46 drugs
| Jardiance | 197 | $235,706 | $1,196 |
| Rybelsus | 134 | $186,434 | $1,391 |
| Ozempic | 108 | $121,341 | $1,124 |
| Mounjaro | 55 | $57,223 | $1,040 |
| Trulicity | 39 | $35,483 | $910 |
| Afrezza | 12 | $18,959 | $1,580 |
| Tradjenta | 15 | $16,701 | $1,113 |
| Januvia | 14 | $15,309 | $1,093 |
| Farxiga | 13 | $10,903 | $839 |
| Vascepa | 19 | $10,383 | $546 |
| Semglee (Yfgn) | 23 | $7,255 | $315 |
| Tresiba Flextouch U-100 | 13 | $5,855 | $450 |
| Basaglar Kwikpen U-100 | 20 | $4,065 | $203 |
| Insulin Aspart Flexpen | 14 | $3,198 | $228 |
| Ultra-Fine Mini Pen Needle | 28 | $2,779 | $99 |
| Lantus Solostar | 19 | $1,894 | $100 |
| Atorvastatin | 240 | $1,678 | $7 |
| Rosuvastatin | 43 | $1,210 | $28 |
| Glipizide | 76 | $1,144 | $15 |
| Losartan | 132 | $1,075 | $8 |
| Albuterol Sulfate Hfa | 19 | $701 | $37 |
| Metformin | 127 | $688 | $5 |
| Metoprolol | 49 | $659 | $13 |
| Diclofenac | 23 | $571 | $25 |
| Amlodipine Besylate | 116 | $545 | $5 |
| Metformin Hcl Er | 37 | $415 | $11 |
| Omega-3 Acid Ethyl Esters | 11 | $408 | $37 |
| Triamcinolone Acetonide | 23 | $380 | $17 |
| Levothyroxine | 20 | $348 | $17 |
| Simvastatin | 33 | $330 | $10 |
| Omeprazole | 55 | $315 | $6 |
| Benazepril | 22 | $304 | $14 |
| Gabapentin | 30 | $297 | $10 |
| Pioglitazone | 37 | $295 | $8 |
| Fluticasone Propionate | 33 | $275 | $8 |
| Tamsulosin | 27 | $256 | $9 |
| Ezetimibe | 13 | $201 | $15 |
| Alendronate | 22 | $182 | $8 |
| Famotidine | 15 | $138 | $9 |
| Lisinopril | 24 | $124 | $5 |
| Carvedilol | 21 | $117 | $6 |
| Atenolol | 15 | $109 | $7 |
| Metoprolol | 14 | $89 | $6 |
| Hydrochlorothiazide | 23 | $53 | $2 |
| Ibuprofen | 18 | $49 | $3 |
| Azithromycin | 16 | $43 | $3 |
Year by year
| 2024 | 2,499 | 354 | None | 33% | $797,481 |
| 2023 | 991 | 303 | None | 25% | $241,792 |
| 2022 | 811 | 264 | None | 21% | $128,987 |
| 2021 | 696 | 246 | 0% (0) | 20% | $82,719 |
| 2020 | 648 | 232 | 0% (0) | 23% | $67,456 |
| 2019 | 93 | 52 | 0% (0) | None | $7,006 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Jardiance | 33 | $38,483 | $1,166 |
| Trulicity | 32 | $36,140 | $1,129 |
| Rybelsus | 26 | $32,973 | $1,268 |
| Ozempic | 18 | $21,060 | $1,170 |
| Humulin 70-30 | 14 | $9,322 | $666 |
| Spiriva Respimat | 11 | $6,211 | $565 |
| Wixela Inhub | 17 | $3,485 | $205 |
| Atorvastatin | 107 | $1,781 | $17 |
| Lantus Solostar | 13 | $1,466 | $113 |
| Metformin | 66 | $888 | $13 |
| Losartan | 64 | $795 | $12 |
| Albuterol Sulfate Hfa | 22 | $738 | $34 |
| Glipizide | 22 | $591 | $27 |
| Diclofenac | 29 | $576 | $20 |
| Gabapentin | 13 | $443 | $34 |
| Fluticasone Propionate | 17 | $320 | $19 |
| Amlodipine Besylate | 39 | $278 | $7 |
| Alendronate | 14 | $232 | $17 |
| Simvastatin | 18 | $149 | $8 |
| Carvedilol | 21 | $127 | $6 |
| Lisinopril | 19 | $117 | $6 |
| Furosemide | 14 | $107 | $8 |
| Metoprolol | 14 | $99 | $7 |
| Hydrochlorothiazide | 12 | $96 | $8 |
2022: 17 drugs
| Humulin 70-30 | 13 | $10,141 | $780 |
| Spiriva Respimat | 18 | $9,555 | $531 |
| Stiolto Respimat | 12 | $5,432 | $453 |
| Atorvastatin | 72 | $1,196 | $17 |
| Albuterol Sulfate Hfa | 26 | $709 | $27 |
| Diclofenac | 24 | $667 | $28 |
| Metformin | 57 | $464 | $8 |
| Losartan | 30 | $332 | $11 |
| Amlodipine Besylate | 50 | $321 | $6 |
| Gabapentin | 18 | $258 | $14 |
| Hydrochlorothiazide | 18 | $249 | $14 |
| Lisinopril | 31 | $208 | $7 |
| Glimepiride | 19 | $159 | $8 |
| Glipizide | 15 | $112 | $7 |
| Triamcinolone Acetonide | 12 | $74 | $6 |
| Simvastatin | 11 | $67 | $6 |
| Furosemide | 12 | $54 | $4 |
2021: 14 drugs
| Spiriva Respimat | 15 | $7,229 | $482 |
| Budesonide-Formoterol | 15 | $3,826 | $255 |
| Diclofenac | 29 | $1,574 | $54 |
| Albuterol Sulfate Hfa | 38 | $1,359 | $36 |
| Atorvastatin | 67 | $899 | $13 |
| Ultra-Fine Short Pen Needle | 17 | $838 | $49 |
| Losartan | 40 | $623 | $16 |
| Metformin | 50 | $362 | $7 |
| Gabapentin | 11 | $185 | $17 |
| Lisinopril | 26 | $155 | $6 |
| Amlodipine Besylate | 35 | $130 | $4 |
| Glipizide | 13 | $102 | $8 |
| Simvastatin | 20 | $95 | $5 |
| Metoprolol | 12 | $62 | $5 |
2020: 13 drugs
| Spiriva Respimat | 15 | $6,785 | $452 |
| Humulin 70-30 | 11 | $5,711 | $519 |
| Albuterol Sulfate Hfa | 55 | $2,144 | $39 |
| Atorvastatin | 56 | $1,109 | $20 |
| Metformin | 56 | $486 | $9 |
| Losartan | 44 | $414 | $9 |
| Glipizide Er | 11 | $228 | $21 |
| Fluticasone Propionate | 13 | $174 | $13 |
| Amlodipine Besylate | 28 | $130 | $5 |
| Lisinopril | 16 | $87 | $5 |
| Hydrochlorothiazide | 14 | $62 | $4 |
| Simvastatin | 16 | $55 | $3 |
| Prednisone | 12 | $35 | $3 |
2019: 2 drugs
| Atorvastatin | 12 | $341 | $28 |
| Lisinopril | 12 | $103 | $9 |
Money from drug and device companies
$123 in 2025
| 2025 | 1 | 1 | None | $123 |
| 2024 | 5 | 6 | None | $796 |
| 2023 | 1 | 1 | None | $103 |
| 2022 | 1 | 1 | None | $87 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ipsen Biopharmaceuticals | Iqirvo | $123 | 1 payment
|
See the published payment
| Ipsen Biopharmaceuticals | Meals · 2025-10-23 | Iqirvo | $123 |
See earlier years (2024, 2023, 2022)
2024: $796
| Gilead Sciences | None | $246 | 2 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $150 | 1 payment
|
| Ipsen Biopharmaceuticals | Iqirvo | $143 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $136 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $122 | 1 payment
|
2023: $103
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $103 | 1 payment
|
2022: $87
| Scynexis | None | $87 | 1 payment
|
Professional record
- NPI
- 1639721053
- Licence
- CA 95010560
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 12900 Park Plaza Dr # 3150, Cerritos, CA, 90703
- NPI first listed
- 2019-07-15
- NPI last updated
- 2019-09-04
This is when the NPI record was last certified, not a medical board exam.